PTC Therapeutics PTCT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $827.11M-52.2% | $1.73B-2.7% | $1.78B+0.8% | $1.76B-0.4% | $1.77B+120% | ||
| $447.15M-1.8% | $455.25M+1.9% | $446.89M-12.1% | $508.15M-3.6% | $527.32M-1.3% | ||
| $352.37M+1.5% | $347.14M+3.6% | $334.95M+3.3% | $324.36M+5.1% | $308.6M+2.6% | ||
| $885.44M+2.5% | $863.72M-13.9% | $1B-4.1% | $1.05B-1.2% | $1.06B-4.5% | ||
| $13.02M-98.6% | $938.28M+20.9% | $775.9M+8.0% | $718.37M+0.7% | $713.11M+336% | ||
| 1.6%-52.6pp | 54.2%+10.6pp | 43.6%+2.9pp | 40.7%+0.5pp | 40.2%+77.7pp | ||
| -$167.17M-9.8% | -$152.23M-10.2% | -$138.1M+6.1% | -$147.12M+8.2% | -$160.25M+4.0% | ||
| -$10.17M+43.8% | -$18.09M-646% | $3.31M+165% | -$5.06M-275% | -$1.35M-121% | ||
| —— | —— | $741M+11.2% | $666.09M+2.3% | $651.41M+279% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $751.72M+19.5% | $629.17M+5.8% | $594.84M+264% | ||
| —— | —— | $8.56+22.8% | $6.97+7.1% | $6.51+238% | ||
| $60.03M-93.9% | $977.1M+20.8% | $808.57M+8.3% | $746.42M+0.8% | $740.6M+426% | ||
| 7.3%-49.2pp | 56.5%+11.0pp | 45.4%+3.2pp | 42.3%+0.5pp | 41.8%+69.9pp | ||
| $13.02M-98.6% | $938.28M+20.9% | $775.9M+8.0% | $718.37M+0.7% | $713.11M+336% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is PTC Therapeutics's revenue?
- PTC Therapeutics (PTCT) generated $827.1M in revenue over the trailing twelve months, down 53.3% year over year.
- Is PTC Therapeutics profitable?
- PTC Therapeutics reported $814.8M in net income over the trailing twelve months, a 42.3% net margin.
- What are PTC Therapeutics's profit margins?
- Gross margin is 96.0% and operating margin is 1.6%, with a 42.3% net margin.
- What is PTC Therapeutics's earnings per share?
- PTC Therapeutics's diluted EPS over the trailing twelve months is $9.38.
- Where does PTC Therapeutics's income statement data come from?
- Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
